title: [Interventional closure of atrial septal defects, patent oval foramen and ventricular septal defects].
abstract: Percutaneous transcatheter closure techniques and devices for congenital intracardiac shunts have considerably improved; therefore, catheter closure is now the treatment of choice for atrial septal defects (ASD). This is technically feasible in more than 80% of patients with a secundum ASD and the success rate is higher than 99%. General anesthesia is as a rule unnecessary and the hospital stay is very short. A patent oval foramen (POF) is a potential cause of cryptogenic stroke and peripheral embolisms. The catheter occlusion has many advantages in comparison to lifelong anticoagulation therapy and for some patients it is the only therapeutic option. Randomized trials have shown that interventional closure leads to results which are comparable to drug therapy and for some occlusion systems even evidence of significant advantages compared to drug therapy was found. Even ventricular septal defects (VSD), including perimembraneous and post-myocardial infarction VSDs can be closed by catheter techniques with a high success rate.
authors.affiliation: CardioVasculäres Centrum CVC, Seckbacher Landstraße 65, 60389, Frankfurt, Deutschland.
authors.forename: Marius
authors.initials: M
authors.lastname: Hornung
authors.forename: Jennifer
authors.initials: J
authors.lastname: Franke
authors.forename: Dani
authors.initials: D
authors.lastname: Id
authors.forename: Horst
authors.initials: H
authors.lastname: Sievert
mesh_terms: D006328:Cardiac Catheterization / Q000295:instrumentation* / Q000379:methods*; D006330:Heart Defects, Congenital / Q000175:diagnosis / Q000628:therapy*; D006801:Humans; D011474:Prosthesis Design; D055989:Septal Occluder Device